98 related articles for article (PubMed ID: 30194946)
1. NIR-light and GSH activated cytosolic p65-shRNA delivery for precise treatment of metastatic cancer.
Wang F; Huang Q; Wang Y; Shi L; Shen Y; Guo S
J Control Release; 2018 Oct; 288():126-135. PubMed ID: 30194946
[TBL] [Abstract][Full Text] [Related]
2. Rational design of multimodal therapeutic nanosystems for effective inhibition of tumor growth and metastasis.
Wang F; Huang Q; Wang Y; Zhang W; Lin R; Yu Y; Shen Y; Cui H; Guo S
Acta Biomater; 2018 Sep; 77():240-254. PubMed ID: 30012354
[TBL] [Abstract][Full Text] [Related]
3. Effective delivery of p65 shRNA by optimized Tween 85-polyethyleneimine conjugate for inhibition of tumor growth and lymphatic metastasis.
Xiao J; Duan X; Meng Q; Yin Q; Zhang Z; Yu H; Chen L; Gu W; Li Y
Acta Biomater; 2014 Jun; 10(6):2674-83. PubMed ID: 24525035
[TBL] [Abstract][Full Text] [Related]
4. The inhibition of metastasis and growth of breast cancer by blocking the NF-κB signaling pathway using bioreducible PEI-based/p65 shRNA complex nanoparticles.
Xiao J; Duan X; Yin Q; Miao Z; Yu H; Chen C; Zhang Z; Wang J; Li Y
Biomaterials; 2013 Jul; 34(21):5381-90. PubMed ID: 23591394
[TBL] [Abstract][Full Text] [Related]
5. Efficient RNA delivery by integrin-targeted glutathione responsive polyethyleneimine capped gold nanorods.
Wang F; Zhang W; Shen Y; Huang Q; Zhou D; Guo S
Acta Biomater; 2015 Sep; 23():136-146. PubMed ID: 26026304
[TBL] [Abstract][Full Text] [Related]
6. Efficient, dual-stimuli responsive cytosolic gene delivery using a RGD modified disulfide-linked polyethylenimine functionalized gold nanorod.
Wang F; Shen Y; Zhang W; Li M; Wang Y; Zhou D; Guo S
J Control Release; 2014 Dec; 196():37-51. PubMed ID: 25284820
[TBL] [Abstract][Full Text] [Related]
7. Tumor environment differentiated "nanodepot" programmed for site-specific drug shuttling and combinative therapy on metastatic cancer.
Dong Q; Zhang H; Han Y; Djamila A; Cheng H; Tang Z; Zhou J; Ding Y
J Control Release; 2018 Aug; 283():59-75. PubMed ID: 29803613
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous inhibition of metastasis and growth of breast cancer by co-delivery of twist shRNA and paclitaxel using pluronic P85-PEI/TPGS complex nanoparticles.
Shen J; Sun H; Xu P; Yin Q; Zhang Z; Wang S; Yu H; Li Y
Biomaterials; 2013 Feb; 34(5):1581-90. PubMed ID: 23146437
[TBL] [Abstract][Full Text] [Related]
9. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles.
Yi Y; Kim HJ; Mi P; Zheng M; Takemoto H; Toh K; Kim BS; Hayashi K; Naito M; Matsumoto Y; Miyata K; Kataoka K
J Control Release; 2016 Dec; 244(Pt B):247-256. PubMed ID: 27590214
[TBL] [Abstract][Full Text] [Related]
10. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
11. Tumor site-specific silencing of NF-kappaB p65 by targeted hollow gold nanosphere-mediated photothermal transfection.
Lu W; Zhang G; Zhang R; Flores LG; Huang Q; Gelovani JG; Li C
Cancer Res; 2010 Apr; 70(8):3177-88. PubMed ID: 20388791
[TBL] [Abstract][Full Text] [Related]
12. Cooperative Treatment of Metastatic Breast Cancer Using Host-Guest Nanoplatform Coloaded with Docetaxel and siRNA.
Wang D; Wang T; Xu Z; Yu H; Feng B; Zhang J; Guo C; Yin Q; Zhang Z; Li Y
Small; 2016 Jan; 12(4):488-98. PubMed ID: 26662850
[TBL] [Abstract][Full Text] [Related]
13. Treatment of metastatic breast cancer by combination of chemotherapy and photothermal ablation using doxorubicin-loaded DNA wrapped gold nanorods.
Wang D; Xu Z; Yu H; Chen X; Feng B; Cui Z; Lin B; Yin Q; Zhang Z; Chen C; Wang J; Zhang W; Li Y
Biomaterials; 2014 Sep; 35(29):8374-84. PubMed ID: 24996756
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo.
Zhan C; Wei X; Qian J; Feng L; Zhu J; Lu W
J Control Release; 2012 Jun; 160(3):630-6. PubMed ID: 22410115
[TBL] [Abstract][Full Text] [Related]
15. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
Luan X; Rahme K; Cong Z; Wang L; Zou Y; He Y; Yang H; Holmes JD; O'Driscoll CM; Guo J
Eur J Pharm Biopharm; 2019 Apr; 137():56-67. PubMed ID: 30779980
[TBL] [Abstract][Full Text] [Related]
16. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.
Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y
Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734
[TBL] [Abstract][Full Text] [Related]
17. Charge-reversal-functionalized PLGA nanobubbles as theranostic agents for ultrasonic-imaging-guided combination therapy.
Yang H; Shen X; Yan J; Xie X; Chen Z; Li T; Li S; Qin X; Wu C; Liu Y
Biomater Sci; 2018 Aug; 6(9):2426-2439. PubMed ID: 30040100
[TBL] [Abstract][Full Text] [Related]
18. Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA.
Kang Y; Lu L; Lan J; Ding Y; Yang J; Zhang Y; Zhao Y; Zhang T; Ho RJY
Acta Biomater; 2018 Mar; 68():137-153. PubMed ID: 29288085
[TBL] [Abstract][Full Text] [Related]
19. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
20. Delivery of small interfering RNA against Nogo-B receptor via tumor-acidity responsive nanoparticles for tumor vessel normalization and metastasis suppression.
Wang B; Ding Y; Zhao X; Han X; Yang N; Zhang Y; Zhao Y; Zhao X; Taleb M; Miao QR; Nie G
Biomaterials; 2018 Aug; 175():110-122. PubMed ID: 29803999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
